Postmarketing herbs clinical evaluation should concern about re-evaluating symptoms

Zhongguo Zhongyao Zazhi

Volumn 35, Issue 11, 2010, Pages 1498-1500

  He, Wei ^a   Xie, Yanming ^a   Wang, Yongyan ^a  

^a INSTITUTE OF CHINESE MATERIA MEDICA   (China)

Author keywords

Re evaluation of clinical postmarketing herbs; Symptoms; Traditional Chinese medicine

Indexed keywords

HERBACEOUS AGENT;

ARTICLE; CHINESE MEDICINE; CLINICAL EVALUATION; DRUG MARKETING; DRUG SAFETY; MEDICAL RESEARCH; POSTMARKETING SURVEILLANCE; SYMPTOM; ADVERSE DRUG REACTION; CHINA; CLINICAL TRIAL (TOPIC); DRUG THERAPY; HUMAN; STANDARDS;

CHINA; CLINICAL TRIALS AS TOPIC; DRUG THERAPY; DRUG TOXICITY; DRUGS, CHINESE HERBAL; HUMANS; PRODUCT SURVEILLANCE, POSTMARKETING; DRUG-RELATED SIDE EFFECTS AND ADVERSE REACTIONS;

EID: 77956101449     PISSN: 10015302     EISSN: None     Source Type: Journal    
DOI: 10.4268/cjcmm20101131     Document Type: Article

References (5)